Search Scholars Central
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
Advanced searchHide advanced search
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
Rapid communication · 23 Sep 2022 Conference abstract Population pharmacokinetics and pharmacodynamics modeling of β-lactams in critically ill patients with severe sepsis: sulbactam study model to optimize dosage regimens
The emergence of multidrug-resistant (MDR) microorganisms worldwide has become a significant
Conference abstract · 16 Sep 2020 Pharmacodynamics model of the effect of gliclazide therapy on Hemoglobin A1C in response in patients with type 2 diabetes
Diabetes is a global health issue that affects more than 425 million
Article · 28 Jun 2023 In oncology, population pharmacokinetic?pharmacodynamic modelling
relationships can be difficult to interpret. Parametric time-to-event models and population pharmacokinetic– pharmacodynamic modeling are increasingly being used to address this issue
Article · 6 Nov 2023 Pharmacokinetic/Pharmacodynamic Model for Aptensio XRandreg; (an Extended-Release Methylphenidate Formulation) in 6-12 year-old Children
delayed, slow first-order release. The current study investigated a Pharmacokinetic (PK) and Pharmacodynamic (PD) model for children 6-12 years-old (N=15). Determination of the PK parameters’ accuracy
Review article · 2011 Analysis of Pharmacokinetic and Pharmacodynamic Models in Oral and Transdermal Dosage Forms
absorption the drug plays the important role in which the body react i.e. the pharmacodynamics process. Oral drugs, Transdermal drugs, Lipophilic drugs and combined oral drugs all plays the different ... absorption is…
Conference abstract · 29 Aug 2022 Assessment of the activity of posaconazole against azole-resistant aspergillus species studied in in vitro pharmacokinetic/ pharmacodynamics model.
efficacy in the majority of Aspergillus strains. An in vitro pharmacokinetic-pharmacodynamics (PK-PD) model was used to examine its potential involvement in primary therapy against azole-resistant IPA. Methods
Conference abstract · 14 Jun 2018 Pharmacokinetics/pharmacodynamics modeling of cyadox against Clostridium perfringens in pigs
perfringens and optimize the dosage regimens using ex vivo pharmacokinetics-pharmacodynamics (PK-PD) modeling. The ileum fluid contained free fraction cyadox of pigs after oral administration
Conference abstract · 11 Aug 2016 Individualized treatment with an optimal risk-benefit in children using pharmacokinetic-pharmacodynamic modeling in pediatric diseases and solid tumors
dosing or allometric scaling, even though most developmental changes in the pharmacokinetics (PK) and pharmacodynamics (PD) are non-linear dynamic processes. The design of dosing regimens for the treatment…
Conference abstract · 30 Jul 2017 Applications of pharmacokinetic/pharmacodynamic models for the development of antimicrobial agents
answered by experimental evidence, and modeling and simulation is a powerful alternative approach. This modeling and simulation approach is of particular need in the field of new anti-infective agents ... lowered by…
Article · 30 Sep 2024 Pharmacodynamical Modelling: Understanding Drug Effects
Opinion · 28 Jun 2023 In Oncology, Population Pharmacokinetic Pharmacodynamic Modelling
Conference abstract Pharmacokinetic/Pharmacodynamic (PK/PD) modeling of anti-neoplastic agents
mimic the pharmacokinetic profiles when assessing the pharmacodynamic response. We used a pharmacodynamic in vitro hollow fiber model of breast cancer to simulate the concentration time profile of (R)-roscovitine…
Research article · 31 Mar 2014 Research of pharmacodynamic estimation model of anti-motion sickness medicine
medicine(AMSM) quickly and accurately. The paper presents a fusion model by Dempster-Shafer evidence theory (DSET) for pharmacodynamic estimation of AMSM. Establishing diagnostic decision-making frame is Θ={effective…
Research article · 30 Aug 2018 Study on the Pharmacodynamic Material Basis of Naomaitong for Cerebral Ischemia Based on vitro Cell Model
cerebral ischemic injury, from the molecular level, using PC12 cells in vitro cell model pharmacodynamics and PK-PD correlation model research, to explain NaomaitongNMTpharmacodynamic material basis for the treatment…
Review article · 2012 The Hollow Fiber Infection Model for Antimicrobial Pharmacodynamics and Pharmacokinetics
closely mimic human kinetics. This is because they do not properly take into account pharmacodynamic actions (what a drug does to the body) and pharmacokinetic actions (what a body does ... hollow fiber bioreactor…
Research article · 2011 Differences in Relative Bioavailability (BA) of Inhalation Insulin Determined using Insulin and Glucose Levels Following Subcutaneous and Inhalation Administration in Humans
glucose infusion rate (GIR), respectively. To explain the observed differences in BA, a pharmacokinetic-pharmacodynamic model was developed and BAs were predicted at different doses of inhalation insulin with…
Conference abstract · 30 Jul 2017 The hollow fiber infection model for antimicrobial pharmacodynamics and pharmacokinetics
recent introduction of the hollow fiber infection model represents an important advancement in the field of in vitro toxicology. Many toxicologists believe in vitro testing methods are a useful, time ... closely mimic…
Conference abstract · 14 Sep 2015 The hollow fiber infection model for antimicrobial pharmacodynamics and pharmacokinetics
closely mimic human kinetics. This is because they do not properly take into account pharmacodynamic actions (what a drug does to the body) and pharmacokinetic actions (what a body does ... hollow fiber bioreactor…
Research article · 14 Jul 2022 Predicting Fluconazole Drug-Drug Interactions Using a Physiologically-based Pharmacokinetic (PBPK) Model
Aim: Physiologically Based Pharmacokinetic (PBPK) model is developed to (1) simulate clinical

